Criswell H E, Simson P E, Knapp D J, Devaud L L, McCown T J, Duncan G E, Morrow A L, Breese G R
Department of Psychiatry, University of North Carolina at Chapel Hill, USA.
J Pharmacol Exp Ther. 1995 Apr;273(1):526-36.
Previous investigations have suggested a relationship between zolpidem binding within specific brain regions and the ability of ethanol or zolpidem to enhance gamma-aminobutyric acid (GABA)-induced inhibition. The purpose of the present study was to extend our electrophysiological analysis to additional brain sites with high levels of zolpidem binding. In the brain regions chosen, red nucleus and globus pallidus, GABA-induced inhibition was shown to be enhanced by either ethanol or zolpidem on some, but not all, neurons. These findings led to the hypothesis that the effect of zolpidem on GABA-induced inhibition would predict the action of ethanol on responses to GABA for that neuron. When zolpidem and ethanol were applied individually to the same neurons in the red nucleus and globus pallidus, those neurons sensitive to zolpidem enhancement of GABA also were sensitive to ethanol. Conversely, if zolpidem did not enhance responses to GABA, ethanol did not enhance responses to GABA at these brain sites. A similar relationship between the abilities of zolpidem and ethanol to enhance GABA-induced inhibition was obtained in 90% of the neurons studied in the medial septum/diagonal band and ventral pallidum. These studies provide further support for the contention that the zolpidem-sensitive GABAA-benzodiazepine isoreceptor also responds to ethanol. Finally, the expression of GABAA subunit mRNAs was analyzed by polymerase chain reaction from micropunches of several brain regions that contain zolpidem binding sites and exhibit sensitivity to ethanol. Polymerase chain reaction analysis proved more sensitive than in situ hybridization in the detection of receptor subunit mRNAs. Several subunits (alpha 1, alpha 2, alpha 3, beta 2, beta 3 and gamma 2) were common to all brain regions in which ethanol and zolpidem enhanced GABA responses. GABAA receptor alpha 4/5, alpha 6, beta 1, gamma 1, gamma 3 and delta subunits were not consistently expressed in association with the presence of zolpidem binding. These data are consistent with the view that one native GABAA receptor to which zolpidem binds, and on which ethanol acts, contains the GABAA receptor subunits alpha 1, beta 2 and gamma 2; however, the present investigation did not preclude the possibility that other subunit combinations can contribute to ethanol and zolpidem enhancement of responses to GABA.
先前的研究表明,唑吡坦在特定脑区的结合与乙醇或唑吡坦增强γ-氨基丁酸(GABA)诱导的抑制作用的能力之间存在关联。本研究的目的是将我们的电生理分析扩展到唑吡坦结合水平较高的其他脑区。在所选的脑区,即红核和苍白球中,在一些但并非所有神经元上,乙醇或唑吡坦均可增强GABA诱导的抑制作用。这些发现导致了这样一种假设,即唑吡坦对GABA诱导的抑制作用的影响可以预测乙醇对该神经元对GABA反应的作用。当将唑吡坦和乙醇分别应用于红核和苍白球中的同一神经元时,那些对唑吡坦增强GABA敏感的神经元对乙醇也敏感。相反,如果唑吡坦不能增强对GABA的反应,那么在这些脑区乙醇也不能增强对GABA的反应。在内侧隔区/斜角带和腹侧苍白球中研究的90%的神经元中,唑吡坦和乙醇增强GABA诱导的抑制作用的能力之间也存在类似的关系。这些研究进一步支持了以下观点:对唑吡坦敏感的GABAA-苯二氮䓬异受体也对乙醇有反应。最后,通过聚合酶链反应对几个含有唑吡坦结合位点且对乙醇敏感的脑区的微量打孔样本进行分析,以检测GABAA亚基mRNA的表达。在检测受体亚基mRNA方面,聚合酶链反应分析比原位杂交更敏感。在所有乙醇和唑吡坦增强GABA反应的脑区中,都有几个亚基(α1、α2、α3、β2、β3和γ2)是共同的。GABAA受体α4/5、α6、β1、γ1、γ3和δ亚基的表达与唑吡坦结合的存在并不一致。这些数据与以下观点一致,即唑吡坦结合且乙醇作用的一种天然GABAA受体含有GABAA受体亚基α1、β2和γ2;然而,本研究并未排除其他亚基组合可能有助于乙醇和唑吡坦增强对GABA反应的可能性。